Page last updated: 2024-09-04

n-desmethylmethoxyphenamine and n-methyl-3,4-methylenedioxyamphetamine

n-desmethylmethoxyphenamine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 2 studies

Compound Research Comparison

Studies
(n-desmethylmethoxyphenamine)
Trials
(n-desmethylmethoxyphenamine)
Recent Studies (post-2010)
(n-desmethylmethoxyphenamine)
Studies
(n-methyl-3,4-methylenedioxyamphetamine)
Trials
(n-methyl-3,4-methylenedioxyamphetamine)
Recent Studies (post-2010) (n-methyl-3,4-methylenedioxyamphetamine)
15024,2762111,392

Protein Interaction Comparison

ProteinTaxonomyn-desmethylmethoxyphenamine (IC50)n-methyl-3,4-methylenedioxyamphetamine (IC50)
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.9351
Sodium-dependent serotonin transporterHomo sapiens (human)1.1761
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)1.06
Sodium-dependent dopamine transporter Homo sapiens (human)1.7609

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glennon, RA1
Inaba, T; Kalow, W; Otton, SV; Sellers, EM; Wu, D1

Other Studies

2 other study(ies) available for n-desmethylmethoxyphenamine and n-methyl-3,4-methylenedioxyamphetamine

ArticleYear
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
    Journal of medicinal chemistry, 2017, 04-13, Volume: 60, Issue:7

    Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin

2017
Interactions of amphetamine analogs with human liver CYP2D6.
    Biochemical pharmacology, 1997, Jun-01, Volume: 53, Issue:11

    Topics: Amphetamines; Binding, Competitive; Cytochrome P-450 CYP2D6 Inhibitors; Humans; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Substrate Specificity

1997